Ryman’s turnaround is well under way: Forsyth Barr

Ryman’s turnaround is well under way: Forsyth Barr
Forsyth Barr's Aaron Ibbotson rates Ryman shares as "outperform". (Image: Forsyth Barr)
Jenny Ruth
Forsyth Barr analyst Aaron Ibbotson has taken a deep dive into Ryman Healthcare‘s debt position and its turnaround strategy and concluded it is “changing its stripes more than the market is giving it credit for”.The market has certainly exhibited extreme disillusion with the stock in recent weeks.Ryman shares fell as low as $4.82 after it completed its $902 million capital raising, compared with the rights issue price of $5 per new share and $6.40 before the mid-February announcement.The shares closed at $5.22 on Tuesday.A goo...

More Markets

NZ sharemarket up over 1.4% for week
Markets Market Close

NZ sharemarket up over 1.4% for week

The S&P/NZX 50 Index closed at 12,287.46, down 18.33 points or 0.15%.

Graham Skellern 28 Mar 2025
Winton ordered to pay Chris Meehan’s former assistant $100k
Markets Free

Winton ordered to pay Chris Meehan’s former assistant $100k

The ERA’s determination stated that Winton had no regard for NZ employment law.

Staff reporters 28 Mar 2025
FMA swings axe as costs blow out
Markets

FMA swings axe as costs blow out

Docs reveal a bad first half of this financial year. 

Victoria Young 28 Mar 2025
Australia momentum continues for Hallenstein Glasson
Retail

Australia momentum continues for Hallenstein Glasson

Glassons' sales in Australia are up 15.8%.

Gregor Thompson 28 Mar 2025